Sodium-Glucose Transporter 2 Inhibitors [glifloziny]
topical
770
- Terms
-
gliflozin
inhibitory SGLT2
inhibitory transportéru 2 pro sodík a glukózu
-
Gliflozin
Gliflozins
SGLT-2 Inhibitor
SGLT-2 Inhibitors
SGLT2 Inhibitor
SGLT2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitor
Persistent link
https://www.medvik.cz/link/D000077203
Definition
Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS.
- DUI
- D000077203 MeSH Browser
- CUI
- M000639744
- History note
- 2019
- Public note
- 2019
Allowable subheadings
- AD
- administration & dosage 105
- AE
- adverse effects 57
- AN
- analysis 1
- BL
- blood 1
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 3
- CL
- classification 10
- EC
- economics 16
- HI
- history 1
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 5
- PK
- pharmacokinetics 15
- PD
- pharmacology 232
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 396
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D27.505.519.143
Amylin Receptor Agonists
D27.505.519.182
Antiglycation Agents
D27.505.519.241
Aversive Agents
D27.505.519.334
Cystine Depleting Agents
D27.505.519.952
Toll-Like Receptor Agonists
D27.505.519.957
Viral Fusion Protein Inhibitors
D27.505.696.422.374
Amylin Receptor Agonists
D27.505.696.422.625
Insulin Secretagogues
D27.505.696.422.688
PPAR-gamma Agonists